Suppr超能文献

正常受试者中DNCB致敏剂量与反应性之间的定量关系。

Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects.

作者信息

Friedmann P S, Moss C, Shuster S, Simpson J M

出版信息

Clin Exp Immunol. 1983 Sep;53(3):709-15.

Abstract

We have developed quantitative methods which enable us to measure susceptibility to sensitization with dinitrochlorobenzene (DNBC) and the degree of responsiveness of groups, and to analyse factors affecting the afferent and efferent components of the response. Five groups of normal subjects (132 individuals) were sensitized with DNCB (1,000, 500, 250, 125 or 62.5 micrograms). One month later, each subject was challenged with 12.5, 6.25 and 3.125 micrograms of DNCB on standard patch test felts. After 48 h the reaction at each challenge site was graded clinically and measured as diameter of induration and increase in skinfold thickness. The proportion of subjects sensitized increased with sensitizing dose; 8% were sensitized by 62.5 and 100% were sensitized by 500 micrograms or more. The 50% sensitizing dose (ED50) was calculated as 116 micrograms. Increase in skinfold thickness proved the best method of assessing response and was linearly related to log challenge dose. There was also a linear relationship between degree of sensitivity and log sensitizing dose so that, on average, each time sensitizing dose was halved, the challenge dose required to produce the same response increased 1.5-fold. These methods can be used to measure sensitizability of a population, the degree of sensitivity and the expression of reactivity. The technique will allow quantitative study of factors altering the induction or expression of such reactivity in disease.

摘要

我们已经开发出定量方法,这些方法使我们能够测量对二硝基氯苯(DNCB)致敏的易感性、各组的反应程度,并分析影响反应传入和传出成分的因素。五组正常受试者(132人)用DNCB(1000、500、250、125或62.5微克)进行致敏。一个月后,在标准斑贴试验滤纸上,给每位受试者分别用12.5、6.25和3.125微克的DNCB进行激发试验。48小时后,对每个激发部位的反应进行临床分级,并测量硬结直径和皮褶厚度增加量。致敏受试者的比例随致敏剂量增加而升高;62.5微克致敏的为8%,500微克或更高剂量致敏的为100%。计算出50%致敏剂量(ED50)为116微克。皮褶厚度增加被证明是评估反应的最佳方法,且与对数激发剂量呈线性相关。敏感性程度与对数致敏剂量之间也存在线性关系,因此,平均而言,每次将致敏剂量减半,产生相同反应所需的激发剂量增加1.5倍。这些方法可用于测量人群的致敏性、敏感程度和反应性表达。该技术将允许对疾病中改变这种反应性诱导或表达的因素进行定量研究。

相似文献

4
Repeated low-dose skin exposure is an effective sensitizing stimulus, a factor to be taken into account in predicting sensitization risk.
Br J Dermatol. 2010 Mar;162(3):594-7. doi: 10.1111/j.1365-2133.2009.09489.x. Epub 2009 Sep 1.
6
Dinitrochlorobenzene contact sensitization in patients with end-stage renal disease.
Allergol Immunopathol (Madr). 1984 Nov-Dec;12(6):479-82.
10
The immunology of allergic contact dermatitis: the DNCB story.
Adv Dermatol. 1990;5:175-95;discussion 196.

引用本文的文献

3
Susceptibility to adverse drug reactions.
Br J Clin Pharmacol. 2019 Oct;85(10):2205-2212. doi: 10.1111/bcp.14015. Epub 2019 Jul 17.
4
Skin sensitization: Uncertainties, challenges, and opportunities for improved risk assessment.
Contact Dermatitis. 2019 Mar;80(3):195-200. doi: 10.1111/cod.13167. Epub 2018 Dec 7.
5
New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
J Allergy Clin Immunol. 2015 Aug;136(2):236-44. doi: 10.1016/j.jaci.2015.06.022.
7
Idiosyncratic adverse drug reactions: current concepts.
Pharmacol Rev. 2013 Mar 8;65(2):779-808. doi: 10.1124/pr.113.007450. Print 2013 Apr.
9
Clarification of terminology in drug safety.
Drug Saf. 2005;28(10):851-70. doi: 10.2165/00002018-200528100-00003.
10
Joining the DoTS: new approach to classifying adverse drug reactions.
BMJ. 2003 Nov 22;327(7425):1222-5. doi: 10.1136/bmj.327.7425.1222.

本文引用的文献

1
IMMUNOLOGIC COMPETENCE OF PATIENTS WITH PSORIASIS RECEIVING CYTOTOXIC DRUG THERAPY.
Arch Dermatol. 1965 Jun;91:599-606. doi: 10.1001/archderm.1965.01600120031006.
2
Histamine weal formation and absorption in man.
Br J Pharmacol. 1980 Aug;69(4):579-85. doi: 10.1111/j.1476-5381.1980.tb07907.x.
3
Attenuation of contact sensitization in man.
J Invest Dermatol. 1968 Mar;50(3):244-9.
4
Impaired immunologic reactivity and recurrence following cancer surgery.
Cancer. 1970 Feb;25(2):362-7. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v.
5
A standrard method for DNCB sensitization testing in patients with neoplasms.
Cancer. 1974 Apr;33(4):911-5. doi: 10.1002/1097-0142(197404)33:4<911::aid-cncr2820330404>3.0.co;2-b.
6
Endogenous cell-mediated immunity, blood transfusion, and outcome of renal transplantation.
Lancet. 1979;2(8156-8157):1323-6. doi: 10.1016/s0140-6736(79)92812-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验